• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Monsanto Announces Second-Quarter Financial Results in Line with Mid-Teens Earnings Growth Opportunity

Company Confirms Full-Year Ongoing Earnings Per Share Guidance, Raises Free Cash Flow Expectation


News provided by

Monsanto Company

Apr 06, 2011, 08:00 ET

Share this article

Share this article


ST. LOUIS, April 6, 2011 /PRNewswire/ -- With half its fiscal year complete, Monsanto Company (NYSE: MON) today said a solid sales season for its U.S. seeds and traits business and disciplined approach to spending have positioned the company to realize its mid-teens earnings growth opportunity this year and set a strong foundation for coming seasons.  In reporting its earnings results for the quarter ending Feb. 28, 2011, the company highlighted performance tracking with projections in both the seeds and genomics and agricultural productivity segments that affirms its full-year ongoing earnings per share guidance.  The company also increased its free cash flow guidance for the full-year, driven by better than expected working-capital management and a strong economic climate in agriculture.





Second Quarter



Six Months

($ in millions)

2011


2010


2011


2010

Net Sales By Segment













Corn seed and traits

$

2,397


$

2,247


$

3,011


$

2,816


Soybean seed and traits


615



633



841



834


Cotton seeds and traits


67



34



179



93


Vegetable seeds


229



223



412



396


All other crops seeds and traits


113



111



141



140

TOTAL Seeds and Genomics

$

3,421


$

3,248


$

4,584


$

4,279















Agricultural productivity

$

708


$

642


$

1,375


$

1,308

TOTAL Agricultural Productivity

$

708


$

642


$

1,375


$

1,308














TOTAL Net Sales

$

4,129


$

3,890


$

5,959


$

5,587














Gross Profit

$

2,308


$

2,099


$

3,126


$

2,838














Operating Expenses

$

823


$

821


$

1,583


$

1,598














Interest Expense – Net

$

20


$

27


$

48


$

55

Other Expense (Income) – Net

$

11


$

2


$

23


$

(10)














Net Income Attributable to Monsanto Company

$

1,017


$

887


$

1,023


$

868














Diluted Earnings per Share (See note 1.)

$

1.88


$

1.60


$

1.88


$

1.57

Items Affecting Comparability – EPS Impact













Restructuring charges


—



0.10



0.01



0.12


Income on discontinued operations


(0.01)



—



—



(0.01)

Diluted Earnings per Share from Ongoing Business (For the definition of ongoing EPS, see note 1.)

$

1.87


$

1.70


$

1.89


$

1.68














Effective Tax Rate


29%



29%



29%



28%






Second Quarter

Six Months

Comparison as a Percent of Net Sales:

2011


2010

2011


2010


Gross profit

56%


54%

52%


51%


Selling, general and administrative expenses (SG&A)

12%


13%

16%


18%


Research and development expenses

8%


7%

10%


10%


Income from continuing operations before income taxes

35%


32%

25%


21%


Net income attributable to Monsanto Company

25%


23%

17%


16%


"We came into this year with an operational plan built around creating value for our customers," said Hugh Grant, chairman, president and chief executive officer for Monsanto.  "It was a plan that was designed for balanced growth – across crops, across geographies and through a combination of mix and volume improvements.  We exist to serve our farmer customers, and it is rewarding to see this plan is resonating with them.  Given the tempo of the year, we are where we should be, and we have the right pieces and the right execution to feel very good that mid-teens earnings growth in 2011 is on track."

Results of Operations

Net sales increased $239 million, or 6 percent, in the three-month comparison driven by volume in both the seeds and genomics and agricultural productivity segments.  Net income in the second quarter was $1 billion.

Gross profit rose 10 percent in the quarter to $2.3 billion, with margins higher due to cost improvements.  For the first six months, gross profit is up 10 percent or $288 million.

Operating expenses were up $2 million in the second quarter compared to the prior year. In the three-month comparison, selling, general and administrative (SG&A) expenses decreased 2 percent.  R&D expenses increased as the company continues to manage more projects in advanced pipeline phases.

Earnings per share (EPS) for the second quarter was $1.88 on an as-reported basis, and $1.87 on an ongoing basis. EPS for the first six months of fiscal year 2011 was $1.88 on an as-reported basis, and $1.89 on an ongoing basis. (For a reconciliation of EPS to ongoing EPS see page 1).

Cash Flow

The second quarter saw a continuation of the strong start to the year.  For the first half of fiscal year 2011, cash flow from operations was a source of $1.4 billion compared to $256 million in the first half last year. Net cash required by investing activities for the first half of fiscal year 2011 was $524 million, compared to $345 million for the same period of fiscal year 2010.  

Net cash required by financing activities for the first half of 2011 was $668 million, compared to net cash required of $259 million for the same period of fiscal year 2010.  The company continues to make progress on its current $1 billion, three-year share repurchase authorization, spending $114 million on repurchases in the second quarter for a total purchase of $381 million for the first half of the fiscal year.

Free cash flow was a source of $917 million for the first half of fiscal year 2011, compared to a use of $89 million for the first half of fiscal year 2010. (For a reconciliation of free cash flow, see note 1.)

Outlook

The company affirmed its previously announced ongoing EPS guidance and raised its full-year free cash flow guidance for fiscal year 2011 to the range of $900 million to $1.1 billion.  The company expects net cash provided by operating activities to be $1.8 billion to $2.1 billion, and net cash required by investing activities to be approximately $900 million to $1 billion for fiscal year 2011. (For a reconciliation of free cash flow, see note 1.)

The company confirmed full-year 2011 ongoing EPS guidance is in the range of $2.72 to $2.82.  Full-year 2011 EPS guidance on an as-reported basis is in the range of $2.66 to $2.79.  (For a reconciliation of EPS, see note 1.)

Seeds and Genomics Segment Detail

($ in millions)


Net Sales


Gross Profit



Second Quarter


Six Months


Second Quarter


Six Months

Seeds and Genomics


2011


2010



2011


2010


2011


2010



2011


2010

Corn Seed and Traits

$

2,397

$

2,247


$

3,011

$

2,816

$

1,506

$

1,420


$

1,845

$

1,724

Soybean Seed and Traits


615


633



841


834


414


386



567


525

Cotton Seed and Traits


67


34



179


93


42


15



116


48

Vegetable Seeds


229


223



412


396


125


138



238


250

All Other Crops Seeds and Traits


113


111



141


140


44


53



44


62

TOTAL Seeds and Genomics

$

3,421

$

3,248


$

4,584

$

4,279

$

2,131

$

2,012


$

2,810

$

2,609




($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)





Second Quarter



Six Months



Seeds and Genomics

2011

2010


2011

2010



EBIT (For a reconciliation of EBIT, see note 1.)

$

1,403

$

1,362


$

1,383

$

1,305



Unusual Items Affecting EBIT: Restructuring

$

(3)

$

(59)


$

(14)

$

(62)



The Seeds and Genomics segment consists of the company's global seeds and related traits business.

In total, sales for Monsanto's Seeds and Genomics segment in the second quarter of fiscal 2011 increased 5 percent or $173 million, driven by global unit volume growth and a mix upgrade in the United States.  

While it's early in the season, the company indicated sales are pacing to meet the mid-teens millions of U.S. acres it had expected for both its Genuity® Roundup Ready 2 Yield® soybeans and the Genuity® reduced refuge corn family this year.  This brings a positive mix improvement across Monsanto's U.S. soybean and corn portfolios.

Globally, the company saw higher branded corn sales in Brazil, the United States and Europe in the quarter.  In U.S. corn, the company has made significant product and pricing strategy moves, identifying lead products in each of the major geographies while making all products available across areas to meet farmers' needs.  Genuity® SmartStax®, which provides the broadest spectrum of insect and weed control, is receiving strong interest in heavy rootworm areas of the Northern Corn Belt.  Genuity® VT Triple PRO® and Genuity® VT Double PRO® are complementing the Genuity® SmartStax® build-out, with Genuity® VT Triple PRO® generating strong interest in the South as Genuity® VT Double PRO® does the same in areas with an established doubles market.  

The cotton business also is performing well this year, with mix and volume improvements led by second-generation trait offerings and continued breeding gains.  The company maintained a positive outlook for vegetables, with the gross profit decline attributed primarily to sales mix timing, which is expected to normalize over the rest of the year.

Agricultural Productivity Segment Detail

($ in millions)

Net Sales

Gross Profit


Second Quarter

Six Months

Second Quarter

Six Months



2011 


2010 


2011 


2010 


2011 


2010 


2011 


2010 

Agricultural Productivity

$

708

$

642

$

1,375

$

1,308

$

177

$

87

$

316

$

229

TOTAL Agricultural Productivity

$

708

$

642

$

1,375

$

1,308

$

177

$

87

$

316

$

229




($ in millions)

Earnings (Loss) Before Interest & Taxes (EBIT)






Second Quarter



Six Months



Agricultural Productivity


2011 



2010 



2011 



2010 



EBIT (For a reconciliation of EBIT, see note 1.)

$

60


$

(87)


$

120


$

(53)



Unusual Items Affecting EBIT:















EBIT from Discontinued Operations

$

4


$

—


$

4


$

5




Restructuring

$

—


$

(25)


$

4


$

(36)



The Agricultural Productivity segment consists of the crop protection products and lawn-and-garden herbicide products.

Over the last year, the company has made fundamental changes in the crop protection business in particular as it relates to Roundup® and other glyphosate-based herbicides.  With this quarter, the structural changes made to this segment are now reflected in the company's financial statements.  

In our Agricultural Productivity reportable segment, the company has consolidated the Roundup® and other glyphosate-based herbicides, selective chemistry and lawn-and-garden businesses.  The company made this change because the Agricultural Productivity segment now is managed as one business, and the ongoing operations of that business reflect the restructuring that is now complete.

Sales in the second quarter of fiscal 2011 for Monsanto's Agricultural Productivity segment increased 10 percent, with gross profit improvement as well as a function of volume and cost improvements primarily related to production efficiencies following the restructuring.  

Webcast Information

In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations and may include a discussion of Monsanto's strategic initiatives, product performance and other matters related to the company's business.

Presentation slides and a simultaneous audio webcast of the conference call may be accessed by visiting the company's web site at www.monsanto.com and clicking on "Investor Information." Visitors may need to download Windows Media Player™ prior to listening to the webcast. Following the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three weeks.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com.  Follow our business on Twitter® at www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at www.monsantoblog.com, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information:

Certain statements contained in this release are "forward-looking statements," such as statements concerning the company's anticipated financial results, current and future product performance, regulatory approvals, business and financial plans and other non-historical facts. These statements are based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company's actual performance and results may differ materially from those described or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, among others: continued competition in seeds, traits and agricultural chemicals; the company's exposure to various contingencies, including those related to intellectual property protection, regulatory compliance and the speed with which approvals are received, and public acceptance of biotechnology products; the success of the company's research and development activities; the outcomes of major lawsuits; developments related to foreign currencies and economies; successful operation of recent acquisitions; fluctuations in commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the company's estimates related to distribution inventory levels; the company's ability to fund its short-term financing needs and to obtain payment for the products that it sells; the effect of weather conditions, natural disasters and accidents on the agriculture business or the company's facilities; and other risks and factors detailed in the company's most recent Form 10-K Report to the SEC. Undue reliance should not be placed on these forward-looking statements, which are current only as of the date of this release. The company disclaims any current intention or obligation to update any forward-looking statements or any of the factors that may affect actual results.

Notes to editors: Roundup, Genuity, SmartStax and Roundup Ready 2 Yield, VT Triple PRO and VT Double PRO are trademarks of Monsanto Company and its wholly-owned subsidiaries.

References to Roundup herbicides in this release mean Roundup-branded herbicides, excluding lawn-and-garden herbicide products.

Monsanto Company

Selected Financial Information

(Dollars in millions, except per share amounts)

Unaudited


Statements of Consolidated Operations


Three Months Ended



Six Months Ended




Feb. 28,



Feb. 28,




2011 



2010 



2011 



2010 

Net Sales

$

4,129


$

3,890


$

5,959


$

5,587

Cost of Goods Sold


1,821



1,791



2,833



2,749

Gross Profit


2,308



2,099



3,126



2,838

Operating Expenses:













Selling, general and administrative expenses


502



512



952



1,008


Research and development expenses


320



279



623



546


Restructuring charges, net


1



30



8



44

Total Operating Expenses


823



821



1,583



1,598

Income From Operations


1,485



1,278



1,543



1,240

Interest Expense


39



41



82



80

Interest Income


(19)



(14)



(34)



(25)

Other Expense (Income), Net


11



2



23



(10)

Income from Continuing Operations Before Income Taxes


1,454



1,249



1,472



1,195

Income Tax Provision


428



360



434



330

Income from Continuing Operations Including Portion













Attributable to Noncontrolling Interest

$

1,026


$

889


$

1,038


$

865

Discontinued Operations:












Income from Operations of Discontinued Businesses


4



—



4



5

Income Tax Provision


1



—



1



—

Income on Discontinued Operations


3



—



3



5

Net Income

$

1,029


$

889


$

1,041


$

870

Less: Net Income Attributable to Noncontrolling Interest


12



2



18



2

Net Income Attributable to Monsanto Company

$

1,017


$

887


$

1,023


$

868














EBIT (see note 1)

$

1,463


$

1,275


$

1,503


$

1,252














Basic Earnings per Share Attributable to Monsanto Company:












Income from Continuing Operations

$

1.89


$

1.63


$

1.90


$

1.58

Income on Discontinued Operations


0.01



—



—



0.01

Net Income Attributable to Monsanto Company

$

1.90


$

1.63


$

1.90


$

1.59














Diluted Earnings per Share Attributable to Monsanto Company:












Income from Continuing Operations

$

1.87


$

1.60


$

1.88


$

1.56

Income on Discontinued Operations


0.01



—



—



0.01

Net Income Attributable to Monsanto Company

$

1.88


$

1.60


$

1.88


$

1.57














Weighted Average Shares Outstanding:













Basic


536.3



545.8



537.6



545.7


Diluted


542.4



553.4



543.7



553.4


Monsanto Company

Selected Financial Information

(Dollars in millions, except per share amounts)

Unaudited


Condensed Statements of Consolidated Financial Position

As of


As of



Feb. 28, 2011


Aug. 31, 2010

Assets






Current Assets:







Cash and cash equivalents (variable interest entities restricted - 2011: $13)

$

1,837


$

1,485


Short-term investments


180



—


Trade receivables, net (variable interest entities restricted - 2011: $101)


2,377



1,590


Miscellaneous receivables


620



717


Deferred tax assets


451



511


Inventory, net


3,090



2,739


Other current assets


137



80

Total Current Assets


8,692



7,122








Property, Plant and Equipment, Net


4,222



4,227

Goodwill


3,320



3,204

Other Intangible Assets, Net


1,353



1,263

Noncurrent Deferred Tax Assets


1,038



1,014

Long-Term Receivables, Net


459



513

Other Assets


565



524

Total Assets

$

19,649


$

17,867








Liabilities and Shareowners' Equity






Current Liabilities:







Short-term debt, including current portion of long-term debt


409



241


Accounts payable


634



752


Income taxes payable


284



66


Accrued compensation and benefits


258



179


Accrued marketing programs


881



839


Deferred revenues


919



219


Grower production accruals


256



130


Dividends payable


150



151


Customer payable


3



83


Restructuring reserves


59



197


Miscellaneous short-term accruals


668



684

Total Current Liabilities


4,521



3,541








Long-Term Debt


1,729



1,862

Postretirement Liabilities


923



920

Long-Term Deferred Revenue


375



395

Noncurrent Deferred Tax Liabilities


143



137

Long-Term Portion of Environmental and Litigation Reserves


179



188

Other Liabilities


645



681

Monsanto Shareowners' Equity


11,001



10,099

Noncontrolling Interest


133



44

Total Shareowners' Equity


11,134



10,143

Total Liabilities and Shareowners' Equity

$

19,649


$

17,867








Debt to Capital Ratio:


16%



17%


Monsanto Company

Selected Financial Information

(Dollars in millions, except per share amounts)

Unaudited


Statements of Consolidated Cash Flows

Six Months Ended Feb. 28,





2011 



2010 

Operating Activities:







Net Income

$

1,041


$

870


Adjustments to reconcile cash provided (required) by operating activities:







Items that did not require (provide) cash:








Depreciation and amortization


310



294



Bad-debt expense


(6)



26



Stock-based compensation expense


55



52



Excess tax benefits from stock-based compensation


(19)



(31)



Deferred income taxes


(13)



(62)



Restructuring charges, net


8



44



Equity affiliate income, net


(8)



(18)



Net gain on sales of a business or other assets


(4)



(2)



Other items


59



38


Changes in assets and liabilities that provided (required) cash, net of acquisitions:








Trade receivables, net


(612)



(459)



Inventory, net


(269)



(241)



Deferred revenues


656



341



Accounts payable and other accrued liabilities


507



(323)



Restructuring cash payments


(152)



(124)



Pension contributions


(44)



(86)



Net investment hedge settlement


—



(4)



Other items


(68)



(59)

Net Cash Provided by Operating Activities


1,441



256









Cash Flows Required by Investing Activities:








Purchases of short-term investments


(180)



—



Capital expenditures


(217)



(342)



Acquisitions of businesses, net of cash acquired


(99)



(23)



Purchases of long-term equity securities


—



(8)



Technology and other investments


(44)



(14)



Other investments and property disposal proceeds


16



42

Net Cash Required by Investing Activities


(524)



(345)









Cash Flows Required by Financing Activities:








Net change in financing with less than 90-day maturities


(12)



126



Short-term debt proceeds


45



25



Short-term debt reductions


(27)



(32)



Long-term debt reductions


(2)



(1)



Payments on other financing


(2)



(1)



Treasury stock purchases


(381)



(124)



Stock option exercises


37



38



Excess tax benefits from stock-based compensation


19



31



Tax withholding on restricted stock and restricted stock units


(4)



—



Dividend payments


(302)



(290)



Proceeds from noncontrolling interests


8



—



Dividend payments to noncontrolling interests


(47)



(31)

Net Cash Required by Financing Activities


(668)



(259)

Cash Assumed from Initial Consolidations of Variable Interest Entities


77



—

Effect of Exchange Rate Changes on Cash and Cash Equivalents


26



(1)

Net Increase (Decrease) in Cash and Cash Equivalents


352



(349)

Cash and Cash Equivalents at Beginning of Period


1,485



1,956

Cash and Cash Equivalents at End of Period

$

1,837


$

1,607


Monsanto Company

Selected Financial Information

(Dollars in millions)

Unaudited


1.

EBIT, Ongoing EPS and Free Cash Flow:  The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP.




Reconciliation of EBIT to Net Income (Loss):  EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto.




Three Months Ended


Six Months Ended




Feb. 28,


Feb. 28,





2011 



2010 



2011 



2010 



EBIT – Seeds and Genomics Segment  

$

1,403


$

1,362


$

1,383


$

1,305



EBIT – Agricultural Productivity Segment


60



(87)



120



(53)



EBIT– Total  


1,463



1,275



1,503



1,252



Interest Expense, Net


20



27



48



55



Income Tax Provision(A)


426



361



432



329



Net Income Attributable to Monsanto Company

$

1,017


$

887


$

1,023


$

868


(A)  

Includes the income tax provision from continuing operations, the income tax benefit (provision) on noncontrolling interest, and the income tax provision on discontinued operations.

Reconciliation of EPS to Ongoing EPS:  Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations.




Fiscal Year

Six Months




2011 

Ended




Guidance

Feb. 28, 2011



Diluted Earnings per Share

$2.66-$2.79

$1.88



Restructuring Charges, Net

$0.03 - $0.06

$0.01



Income on Discontinued Operations

—

—



Diluted Earnings per Share from Ongoing Business

$2.72-$2.82

$1.89



Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating activities and investing activities, as reflected in the Statements of Consolidated Cash Flows presented in this release. With respect to the fiscal year 2011 free cash flow guidance, Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing Activities because in order to prepare any such estimate or projection, Monsanto would need to rely on market factors and conditions that are outside of its control.




Fiscal Year


Six Months Ended




2011 


Feb. 28,




Guidance


2011 


2010 



Net Cash Provided by Operating Activities

$

1,800-2,100

$

1,441

$

256



Net Cash Required by Investing Activities


(900)-(1,000)


(524)


(345)



Free Cash Flow

$

900-1,100


917


(89)



Net Cash Required by Financing Activities


N/A


(668)


(259)



Cash Assumed from Initial Consolidations of Variable Interest Entities


N/A


77


—



Effect of Exchange Rate Changes on Cash and Cash Equivalents


N/A


26


(1)



Net Increase (Decrease) in Cash and Cash Equivalents


N/A


352


(349)



Cash and Cash Equivalents at Beginning of Period


N/A


1,485


1,956



Cash and Cash Equivalents at End of Period


N/A

$

1,837

$

1,607



CONTACT

Media:      Kelli Powers  (314-694-4003)


Analysts:  Bryan Hurley (314-694-8148)

SOURCE Monsanto Company

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.